Register update: there will be a delay adding new records during our holiday period (Dec 17 - Jan 4)
Cochrane COVID-19 Study Register
Study record
NCT04657406First Published: 2020 Dec 8Updated Date: 2020 Dec 8

Expanded Access to ZofinTM (OrganicellTM Flow) for the Treatment of Patients With Mild to Moderate COVID-19 Due to SARS-Cov-2 for Outpatient and Inpatient Population

  1. Study Type
  2. Other
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
Reference record

Expanded Access to ZofinTM (OrganicellTM Flow) for Patients With COVID-19

Trial registry record
No Results
This expanded access protocol will provide access to the investigational product ZofinTM (OrganicellTM Flow) for patients in outpatient facilities infected with SARS-CoV-2 who have mild to moderate COVID-19, or who are judged by a healthcare provider to be at high risk of progression to moderate disease